NasdaqGM - Delayed Quote • USD
Revance Therapeutics, Inc. (RVNC)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BERAUD JILL Director | Stock Award(Grant) | May 3, 2023 | 28,606 |
| FOLEY MARK J Chief Executive Officer | Purchase | Mar 6, 2024 | 1,126,380 |
| GANGOLLI JULIAN S Director | Stock Award(Grant) | May 3, 2023 | 30,106 |
| JORDAN ERICA Officer | Sale | Apr 16, 2024 | 114,864 |
| KOLAJA CAREY O CONNOR Director | Sale | Jun 15, 2023 | 16,561 |
| MOXIE DWIGHT General Counsel | Sale | Mar 18, 2024 | 137,815 |
| RUSSELL ANGUS CHARLES Director | Stock Award(Grant) | May 3, 2023 | 36,506 |
| SCHILKE TOBIN C Chief Financial Officer | Sale | Mar 18, 2024 | 192,666 |
| SJUTS DUSTIN S President | Sale | Mar 18, 2024 | 167,550 |
| WARE OLIVIA C Director | Stock Award(Grant) | May 3, 2023 | 16,675 |
Related Tickers
AMLX Amylyx Pharmaceuticals, Inc.
1.7600
-1.12%
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
FATE Fate Therapeutics, Inc.
3.8000
-1.81%
KPTI Karyopharm Therapeutics Inc.
1.0600
0.00%
ARQT Arcutis Biotherapeutics, Inc.
8.47
-1.40%
SAGE Sage Therapeutics, Inc.
13.69
+0.81%
ABEO Abeona Therapeutics Inc.
3.2600
+2.19%
CHRS Coherus BioSciences, Inc.
2.0400
+5.70%
OCUL Ocular Therapeutix, Inc.
4.7450
+12.98%
TVTX Travere Therapeutics, Inc.
5.26
-2.41%